Skip to main content

Table 4 Clinical outcomes at 1 and 6 months of follow-up (n = 152)

From: The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study

Clinical outcomes

Low GRACE group (N = 88)

Intermediate to high GRACE group (N = 64)

P-value

In-hospital mortality, n (%)

0 (0)

2 (3.1)

0.095

At 1 month

 Composite outcomes

2 (2.3)

10 (15.6)

0.003

 ACS

1 (1.1)

1 (1.6)

0.666

 Heart failure

1 (1.1)

6 (9.4)

0.022

 Stroke

0 (0)

1 (1.6)

0.421

 CV death

0 (0)

2 (3.1)

0.180

 Non-CV death

0 (0)

0 (0)

NS

 Loss to follow-up

2 (2.3)

2 (3.1)

0.562

At 6 month (cumulative)

 Composite outcomes

6 (6.8)

12 (18.7)

0.024

 ACS

4 (4.5)

1 (1.6)

0.298

 Heart failure

2 (2.3)

7 (10.9)

0.036

 Stroke

0 (0)

2 (3.1)

0.421

 CV death

0 (0)

2 (3.1)

0.175

 Non-CV death

0 (0)

0(0)

NS

 Loss to follow-up

2 (2.3)

2 (3.1)

0.562